Gilda Maria Barbaro Del Negro

Dr. Gilda Maria Barbaro Del Negro

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2018 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
Danilo Yamamoto ThomazDanilo Yamamoto Thomaz
Danilo Yamamoto Thomaz
JAJoão Nobrega de Almeida
João Nobrega de Almeida
GLGlaucia Moreira Espindola Lima
Glaucia Moreira Espindola Lima
MNMaína de Oliveira Nunes
Maína de Oliveira Nunes
Carlos Henrique CamargoCarlos Henrique Camargo
Carlos Henrique Camargo
GNGilda Maria Barbaro Del Negro
Gilda Maria Barbaro Del Negro
The incidence of candidemia by the Candida parapsilosis complex has increased considerably in recent decades, frequently related to use of indwelling intravascular catheters. The ability of this pathogen to colonize healthcare workers (HCW)' hands, and to form biofilm on medical devices has been associated with the occurrence of nosocomial outbreaks and high mortality rates. Fluconazole has been the leading antifungal drug for the treatment of invasive candidiasis in developing countries. However, azole-resistant C. parapsilosis isolates are emerging worldwide, including in Brazil. Few studies have correlated outbreak infections due to C. parapsilosis with virulence factors, such as biofilm production. We thus conducted a microbiological investigation of C. parapsilosis complex isolates from a Brazilian teaching hospital. Additionally, we identified a previously unrecognized outbreak caused by a persistent azole-resistant C. parapsilosis (sensu stricto) clone in the intensive care unit (ICU), correlating it with the main clinical data from the patients with invasive candidiasis. The molecular identification of the isolates was carried out by PCR-RFLP assay; antifungal susceptibility and biofilm formation were also evaluated. The genotyping of all C. parapsilosis (sensu stricto) was performed by microsatellite analysis and the presence of ERG11 mutations was assessed in the azole non-susceptible isolates. Fourteen C. parapsilosis (sensu stricto) isolates were recovered from patients with invasive candidiasis, eight being fluconazole and voriconazole-resistant, and two intermediate only to fluconazole (FLC). All non-susceptible isolates showed a similar pattern of biofilm formation with low biomass and metabolic activity. The A395T mutation in ERG11 was detected exclusively among the azole-resistant isolates. According to the microsatellite analysis, all azole non-susceptible isolates from the adult ICU were clustered together indicating the occurrence of an outbreak. Regarding clinical data, all patients infected by the clonal non-susceptible isolates and none of the patients infected by the susceptible isolates had been previously exposed to corticosteroids (p = 0.001), while the remaining characteristics showed no statistical significance. The current study revealed the persistence of an azole non-susceptible C. parapsilosis clone with low capacity to form biofilm over two years in the adult ICU. These results reinforce the need of epidemiological surveillance and monitoring antifungal susceptibility of C. parapsilosis isolates in hospital wards.

30 March 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Danilo Yamamoto ThomazDanilo Yamamoto Thomaz
Danilo Yamamoto Thomaz
JJJoão Nobrega De Almeida Júnior
João Nobrega De Almeida Júnior
OSODELI NICOLE ENCINAS SEJAS
ODELI NICOLE ENCINAS SEJAS
GNGilda Maria Barbaro Del Negro
Gilda Maria Barbaro Del Negro
GCGabrielle O. M. H. Carvalho
Gabrielle O. M. H. Carvalho
GBGil Benard
Gil Benard
Clonal outbreaks due to azole-resistant Candida parapsilosis (ARCP) isolates have been reported in numerous studies, but the environmental niche of such isolates has yet to be defined. Herein, we aimed to identify the environmental niche of ARCP isolates causing unremitting clonal outbreaks in an adult ICU from a Brazilian cancer referral center. C. parapsilosis sensu stricto isolates recovered from blood cultures, pericatheter skins, healthcare workers (HCW), and nosocomial surfaces were genotyped by multilocus microsatellite typing (MLMT). Antifungal susceptibility testing was performed by the EUCAST (European Committee for Antimicrobial Susceptibility Testing) broth microdilution reference method and ERG11 was sequenced to determine the azole resistance mechanism. Approximately 68% of isolates were fluconazole-resistant (76/112), including pericatheter skins (3/3, 100%), blood cultures (63/70, 90%), nosocomial surfaces (6/11, 54.5%), and HCW’s hands (4/28, 14.2%). MLMT revealed five clusters: the major cluster contained 88.2% of ARCP isolates (67/76) collected from blood (57/70), bed (2/2), pericatheter skin (2/3), from carts (3/7), and HCW’s hands (3/27). ARCP isolates were associated with a higher 30 day crude mortality rate (63.8%) than non-ARCP ones (20%, p = 0.008), and resisted two environmental decontamination attempts using quaternary ammonium. This study for the first time identified ARCP isolates harboring the Erg11-Y132F mutation from nosocomial surfaces and HCW’s hands, which were genetically identical to ARCP blood isolates. Therefore, it is likely that persisting clonal outbreak due to ARCP isolates was fueled by environmental sources. The resistance of Y132F ARCP isolates to disinfectants, and their potential association with a high mortality rate, warrant vigilant source control using effective environmental decontamination.

20 January 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Danilo Yamamoto ThomazDanilo Yamamoto Thomaz
Danilo Yamamoto Thomaz
GNGilda Maria Barbaro Del Negro
Gilda Maria Barbaro Del Negro
LRLeidiane B. Ribeiro
Leidiane B. Ribeiro
MSMirian da Silva
Mirian da Silva
GCGabrielle O. M. H. Carvalho
Gabrielle O. M. H. Carvalho
GBGil Benard
Gil Benard
Horizontal transmission of fluconazole-resistant Candida parapsilosis (FRCP) through healthcare workers’ hands has contributed to the occurrence of candidemia outbreaks worldwide. Since the first COVID-19 case in Brazil was detected in early 2020, hospitals have reinforced hand hygiene and disinfection practices to minimize SARS-CoV-2 contamination. However, a Brazilian cardiology center, which shares ICU patients with a cancer center under a FRCP outbreak since 2019, reported an increased FRCP candidemia incidence in May 2020. Therefore, the purpose of this study was to investigate an inter-hospital candidemia outbreak caused by FRCP isolates during the first year of the COVID-19 pandemic in Brazil. C. parapsilosis bloodstream isolates obtained from the cancer (n = 35) and cardiology (n = 30) centers in 2020 were submitted to microsatellite genotyping and fluconazole susceptibility testing. The ERG11 gene of all isolates from the cardiology center was sequenced and compared to the corresponding sequences of the FRCP genotype responsible for the cancer center outbreak in 2019. Unprecedentedly, most of the FRCP isolates from the cardiology center presented the same genetic profile and Erg11-Y132F mutation detected in the strain that has been causing the persistent outbreak in the cancer center, highlighting the uninterrupted horizontal transmission of clonal isolates in our hospitals during the COVID-19 pandemic.

1 June 2016 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
HBHumberto Fabio Boatto
Humberto Fabio Boatto
SCSarah Desirée Barbosa Cavalcanti
Sarah Desirée Barbosa Cavalcanti
GNGilda Maria Barbaro Del Negro
Gilda Maria Barbaro Del Negro
MGManoel João Bc Girão
Manoel João Bc Girão
EFElaine Cristina Francisco
Elaine Cristina Francisco
OGOlga Fischman Gompertz
Olga Fischman Gompertz
The aim of this study was to identify Candida species isolated from women diagnosed with recurrent vulvovaginal candidiasis (RVVC) and their partners; and to evaluate the fluconazole (FLZ) susceptibility of the isolates. In a period of six years, among 172 patients diagnosed with vulvovaginal candidiasis, 13 women that presented RVVC and their partners were selected for this investigation. The isolates were obtained using Chromagar Candida medium, the species identification was performed by phenotypic and molecular methods and FLZ susceptibility was evaluated by E-test. Among 26 strains we identified 14 Candida albicans, six Candida duobushaemulonii, four Candida glabrata, and two Candida tropicalis. Agreement of the isolated species occurred in 100% of the couples. FLZ low susceptibility was observed for all isolates of C. duobushaemulonii (minimal inhibitory concentration values from 8-> 64 µg/mL), two C. glabrata isolates were FLZ-resistant and all C. albicans and C. tropicalis isolates were FLZ-susceptible. This report emphasises the importance of accurate identification of the fungal agents by a reliable molecular technique in RVVC episodes besides the lower antifungal susceptibility profile of this rare pathogen C. duobushaemulonii to FLZ.

1 January 2007 in Ultrastructural Pathology
Verified
Journal Article
Closed access
PVPaulo Velho
Paulo Velho
VPVanessa Pimentel
Vanessa Pimentel
GNGilda Maria Barbaro Del Negro
Gilda Maria Barbaro Del Negro
TOThelma Suely Okay
Thelma Suely Okay
PDPedro Paulo Vissotto de Paiva Diniz
Pedro Paulo Vissotto de Paiva Diniz
Edward BreitschwerdtEdward Breitschwerdt
Edward Breitschwerdt
Bartonella spp. constitute emerging pathogens of worldwide distribution. Bacillary angiomatosis is the most frequent skin manifestation of bartonelloses; nevertheless, B. henselae infection should always be considered systemic, especially in immunodeficient individuals. The authors report the case of an AIDS patient with bacillary angiomatosis, who had concurrent severe anemia, hepatitis, peritonitis, pleuritis, and pericarditis. Clinical manifestation, electronic microscopic examination of erythrocytes, and histopathology of a papule biopsy suggested a Bartonella sp. infection. Multiple genes were target by PCR and B. henselae DNA was amplified and sequenced (GenBank accession number EF196804) from the angiomatous papule. Treatment with clarithromycin resulted in resolution of the bacillary angiomatosis, fever, anemia, panserosites, and hepatitis.

1 October 1992 in Mycopathologia
Verified
Journal Article
Closed access
PDF file
MSMaria Aparecida Shikanai-Yasuda
Maria Aparecida Shikanai-Yasuda
ASAluisio Cotrim Segurado
Aluisio Cotrim Segurado
WPW. Pereira Pinto
W. Pereira Pinto
ANA. C. Nicodemo
A. C. Nicodemo
MSMaria Notomi Sato
Maria Notomi Sato
VNV. A. Neto
V. A. Neto